Journals / Türkiye Acil Tıp Dergisi / 2011 / Cilt: 11 - Sayı: 1

Yeni bir ağrı ölçüm yönteminin güvenilirliği ve geçerliliği: ağrının resimsel olarak gösterimi

Pages
3–8
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

And the overall correlation coefficient was 0.96 (95% CI: 0.96 to 0.97).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ObjectivesThe aim of this study was to determine the reliability and validity of a new pain measurement tool, Pictorial Representation of Pain (PRP), in order to determine its ability to measure the intensity of pain and burden of pain for patients in Emergency Department (ED).MethodsPictorial Representation of Illness and Self Measure (PRISM) has been used as a tool in psychiatric interviews in order to determine the burden of an illness.
📊
Key Findings & Data:Study patients were asked to rate their pain levels at 0, 1, 30, 31, 60 and 61 minutes with PRP and a verbal descriptive scale in order to determine the minimum clinically significant difference.
💡
Conclusion & Impact:And the overall correlation coefficient was 0.96 (95% CI: 0.96 to 0.97).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

ObjectivesThe aim of this study was to determine the reliability and validity of a new pain measurement tool, Pictorial Representation of Pain (PRP), in order to determine its ability to measure the intensity of pain and burden of pain for patients in Emergency Department (ED).MethodsPictorial Representation of Illness and Self Measure (PRISM) has been used as a tool in psychiatric interviews in order to determine the burden of an illness. With modification, a new software named PRP was developed for use in Akdeniz University Hospital ED (Antalya, Turkey). Patients presented to the ED with acute pain were enrolled into the study. Study patients were asked to rate their pain levels at 0, 1, 30, 31, 60 and 61 minutes with PRP and a verbal descriptive scale in order to determine the minimum clinically significant difference. ResultsA total of 246 patients were included into the study with mean age of 40.6±15.4. Eighty seven (35%) were men. The correlation coefficient between PRP scores one minute apart were 0.95 (95% CI: 0.94 to 0.96), 0.95 (95% CI: 0.93 to 0.96) and 0.98 (95% CI: 0.83 to 0.99) at the three preset time (0 min, 30 min, 60 min) respectively. And the overall correlation coefficient was 0.96 (95% CI: 0.96 to 0.97). The minimum clinically significant change in pain was 28.7 mm (95% CI: 27 to 30) with a median of 28 mm (IQR: 23-34, 95% CI: 26 to 30).ConclusionsPRP could be considered as a reliable and consistent tool for measuring the intensity of pain. However, further studies are needed to determine the use of PRP in measuring burden of pain.

🔖

Cite This Article

KORKMAZ, N., ASİLKAN, Ö., ÇETE, Y., BEKTAŞ, F., BİLGE, U., KÜÇÜKYILMAZ, O., ANKUN, G., EKEN, C. (2022). Yeni bir ağrı ölçüm yönteminin güvenilirliği ve geçerliliği: ağrının resimsel olarak gösterimi. Türkiye Acil Tıp Dergisi, Cilt: 11 - Sayı: 1, 3–8. https://ajindex.com/articles/626012

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. http://www.tuik.gov.tr/VeriBilgi.do?tb_id=6&ust_id=1. (Erişim tarihi: 28.03.2011). 2 http://emedicine.medscape.com/article/775277-overview. (Erişim tarihi: 28.03.2011). 3. http://www.who.int/mediacentre/factsheets/fs330/en/index.html. (Erişim tarihi: 28.03.2011). 4. Ericsson CD, Johnson PC, Dupont HL, Morgan DR, Bitsura JA, de la Cabada FJ. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers’ diarrhea. A placebo-controlled, randomized trial. Ann Intern Med 1987
  2. Noguerado A, Garcia-Polo I, Isasia T, Jimenez ML, Bermudez P, Pita J, et al. Early single dose therapy with ofloxacin for empirical treatment of acute gastroenteritis: a randomised, placebo-controlled double-blind clinical trial. J Antimicrob Chemother 1995
  3. Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute communityacquired gastroenteritis with ciprofloxacin. Clin Infect Dis 1996
  4. Taylor DN, Bourgeois AL, Ericsson CD, Steffen R, Jiang ZD, Halpern J, et al. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers’ diarrhea. Am J Trop Med Hyg 2006
  5. Salam I, Katelaris P, Leigh-Smith S, Farthing MJ. Randomised trial of single-dose ciprofloxacin for travellers’ diarrhoea. Lancet Date of Publication 1994
  6. 344(8936):1537-9. 9. Salam I, Katelaris PH, Leigh-Smith S, et al. A prospecitve, randomised, placebo-controlled trial of single dose ciprofloxacin for the treatment of travellers’ diarrhoea. Gut Date of Publication. 1994
  7. 35(Suppl 2):S30. 10. Riddle MS, Arnold S, Tribble DR. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler’s diarrhea: a systematic review and meta-analysis. Clin Infect Dis 2008
  8. Kaplan MA, Prior MJ, Ash RR, McKonly KI, Helzner EC, Nelson EB. Loperamide simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial. Arch Fam Med 1999
  9. van Loon FP, Bennish ML, Speelman P, Butler C. Double blind trial of loperamide for treating acute watery diarrhoea in expatriates in Bangladesh. Gut 1989
  10. Dettmer A. Loperamide oxide in the treatment of acute diarrhea in adults. Clin Ther 1994
  11. Bergström T, Alestig K, Thorén K, Trollfors B. Symptomatic treatment of acute infectious diarrhoea: loperamide versus placebo in a doubl